tolbutamide has been researched along with Hypoparathyroidism in 1 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasuda, K | 1 |
| Hurukawa, Y | 1 |
| Okuyama, M | 1 |
| Kikuchi, M | 1 |
| Yoshinaga, K | 1 |
1 other study available for tolbutamide and Hypoparathyroidism
| Article | Year |
|---|---|
Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release.
Topics: Calcium; Glucose Tolerance Test; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypopa | 1975 |